Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
Clinical trial NCT05140694 · UNKNOWN
Trial details
- NCT number
- NCT05140694
- Sponsor
- Seoul National University Bundang Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-06-30
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.